Cases and resources in vascular techniques

Prof. Gouëffic and Prof. Saratzis explore the RAF and RAVE studies, two pragmatic RCTs designed to address important clinical and cost-effectiveness questions in PAD. They discuss the value of real-world research, patient involvement, collaboration with government funding bodies, and perseverance in advancing vascular evidence. Discover the studies and the journey behind their development.

Could MRI redefine abdominal aortic aneurysm assessment? Prof. Kak Khee Yeung and Dr Edoardo Pasqui explore the potential of advanced MRI for aortic morphology, flow dynamics, biological characterisation, and rupture risk prediction, while discussing non-contrast imaging, AI-assisted analysis, and the challenges of clinical implementation.

This nationwide Korean cohort study investigated the association between changes in smoking behaviour after PAD diagnosis and subsequent cardiovascular and limb outcomes. Smokers aged over 40 years with PAD were classified according to whether they quit smoking, reduced their cigarette consumption or continued smoking, and were followed for approximately five years.

The 2-year SIRONA results compare sirolimus- and paclitaxel-coated balloons in symptomatic femoropopliteal disease. Explore whether the early non-inferiority of sirolimus translates into sustained clinical outcomes, vessel patency and safety.

A young woman with neurofibromatosis type 1 and severe hypertension despite four antihypertensive drugs presented with a complex renal artery aneurysm. The aneurysm was relatively small, raising an important question: was its size really the main factor driving the decision to treat?

In the second part of this conversation, Dr Alexandros Mallios and Dr William Jennings discuss complex surgical dialysis access strategies, including basilic and brachial vein transpositions, graft selection, perforator vein preparation and technical considerations for successful AVF creation. They also explore the evolution of the "Fistula First" philosophy and the ongoing debate between fistulas and grafts.

Two PVI 2025 studies, two perspectives on DCB therapy: Prof. Bibombe Patrice Mwipatayi discusses long-term outcomes in CLTI and the pharmacokinetic profile and clinical results of a novel limus-derivative DCB.

At 3 years, LIFE-BTK showed sustained efficacy of the resorbable scaffold over PTA, with lower restenosis and comparable safety and limb salvage. The benefit persisted beyond scaffold resorption, although the difference narrowed over time.

A 75-mm saccular juxtarenal aneurysm had rapidly expanded in a patient with weight loss and an inflammatory response. What treatment strategy would you choose in this challenging setting?

In this episode, Dr Alexandros Mallios speaks with Dr William Jennings about the principles guiding surgical arteriovenous fistula creation. From vessel assessment and ultrasound mapping to proximal radial artery fistulas and evolving surgical strategies, the discussion explores the clinical reasoning behind choosing the right access for each patient.